Protective immunity induced by Bacillus anthracis toxin-deficient strains.
about
Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteinsThe cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory DiseasesMurine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibilityAnthrax vaccination strategiesMonoclonal antibody therapies against anthraxContribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccineNovel and unique diagnostic biomarkers for Bacillus anthracis infection.Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax.Identification of a protein subset of the anthrax spore immunome in humans immunized with the anthrax vaccine adsorbed preparation.Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthraxProtective antigen-mediated antibody response against a heterologous protein produced in vivo by Bacillus anthracisGenetic vaccines for anthrax based on recombinant adeno-associated virus vectorsStudy of immunization against anthrax with the purified recombinant protective antigen of Bacillus anthracis.Bacillus anthracis sortase A (SrtA) anchors LPXTG motif-containing surface proteins to the cell wall envelopeOral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen.Vaccination against anthrax with attenuated recombinant strains of Bacillus anthracis that produce protective antigenCell surface-exposed tetanus toxin fragment C produced by recombinant Bacillus anthracis protects against tetanus toxin.Role of toxin functional domains in anthrax pathogenesis.Search for correlates of protective immunity conferred by anthrax vaccine.Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein.Anthrax spores make an essential contribution to vaccine efficacySuppression of dendritic cell activation by anthrax lethal toxin and edema toxin depends on multiple factors including cell source, stimulus used, and function testedAn anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor.Search for Bacillus anthracis potential vaccine candidates by a functional genomic-serologic screen.Serological Correlate of Protection in Guinea Pigs for a Recombinant Protective Antigen Anthrax Vaccine Produced from Bacillus brevis.Salmonella enterica serovar typhimurium expressing a chromosomally integrated copy of the Bacillus anthracis protective antigen gene protects mice against an anthrax spore challenge.Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunityA recombinant Bacillus anthracis strain producing the Clostridium perfringens Ib component induces protection against iota toxinsThe anthrax toxin activator gene atxA is associated with CO2-enhanced non-toxin gene expression in Bacillus anthracisAnthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity.Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.Identification of in vivo-expressed immunogenic proteins by serological proteome analysis of the Bacillus anthracis secretome.Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine.Differential contribution of Bacillus anthracis toxins to pathogenicity in two animal modelsNext-Generation Bacillus anthracis Live Attenuated Spore Vaccine Based on the htrA(-) (High Temperature Requirement A) Sterne Strain.Detoxified lethal toxin as a potential mucosal vaccine against anthrax.Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R.A mathematical simulation of the inflammatory response to anthrax infection.Domain specificity of the human antibody response to Bacillus anthracis protective antigen.Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies
P2860
Q24562788-334A6BED-84AB-478C-BF96-DB1CD919ED68Q26750377-F51CC412-75CF-4766-B712-B89195E93381Q28383436-66B31C35-85D4-4D44-8A7A-E79633BD07F4Q28392248-317CC1FF-279D-4851-ADC6-BA2B92DEA655Q28393072-557A480F-054B-4002-849D-7B913065C810Q28393904-62EBC1FC-922C-4A73-92C9-6EFE67CAD969Q30157179-D5B48D0E-BD2B-4144-B406-85D5C0F4F853Q30651835-B6BA05E0-F3A6-4DAC-BCE1-043AC789A55FQ33222054-7B23E096-AC15-4B99-97AD-98FE1A928B68Q33396429-24A85B8A-6371-4DD0-978A-19834FCA7C61Q33592070-EEBB5279-1302-432F-B4AE-B27B9CB2563AQ33713243-CC768EE6-9708-434E-85D4-0A01EDCA75EBQ33756961-C82D1B1A-D129-49AD-B3A8-AD9EF414C77AQ33855682-28F1A9E7-712F-4246-B3BA-9E4EDC33AEA6Q33883273-66FF0DD7-3E90-4F27-AEA6-0EE8D02C0491Q34000174-6FA34C65-3B0D-4445-A066-BCF7963BB84EQ34001881-5D30B7AE-C289-45A3-9A1B-F67932D1E687Q34003762-7A25C6DA-6B1D-4E22-89E8-4F1568AC94F8Q34007168-1AAFA970-D2C9-4094-986C-C45BF1EBDD15Q34008307-73B3DA62-1C39-44D9-BF2E-73F4B5B13925Q34117857-577538A0-7592-4DD9-AEB9-4D9E1DE5253DQ34364568-F24F2346-1D1E-4D12-8F3D-8693C9239300Q34433313-02BFC264-F827-4445-A263-666729379501Q34721071-F91C3A58-979E-4DD6-908F-DC8B1FB4DC2FQ35026166-C52DCB21-7A0A-4763-9567-41F4FC4F112BQ35106528-1315C4E5-3A46-4715-9B98-3663F2B4160FQ35161514-0053E294-D05C-4CBF-B780-BD7767935BD7Q35548328-96C4DCC5-EBF8-407C-9329-3BD63DAE5BF0Q35552160-7DE72F2F-1BFE-45F6-AFF9-60741081D8E8Q35599606-BBD675FC-6D71-4C95-A55C-4DF8BB800979Q35783791-96EBCDEB-3B62-4BEC-856F-833456C1D08BQ35913411-E32648D7-3767-40F9-A2B4-FBB781313931Q35914307-0174272A-872D-4B65-8DED-CBD63AE7C1E9Q36211202-FBFFF8B6-E349-4EEC-90C2-74079BBE4C28Q36432828-C7D27571-AE20-47AE-B013-741C3E79C542Q36539063-0918A7CA-DDCD-4221-87A5-5E401A044E08Q36735532-51C76497-3004-4953-8C5B-EED7C0827518Q36846447-D6F7F732-CB94-4674-86F6-FAF4615BCD06Q36876723-98FD089B-02DE-4A7E-8F8D-C213D7A481F0Q37033046-CFF06F42-7AE6-4C3B-B12D-E3210DD11B67
P2860
Protective immunity induced by Bacillus anthracis toxin-deficient strains.
description
1995 nî lūn-bûn
@nan
1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Protective immunity induced by Bacillus anthracis toxin-deficient strains.
@ast
Protective immunity induced by Bacillus anthracis toxin-deficient strains.
@en
type
label
Protective immunity induced by Bacillus anthracis toxin-deficient strains.
@ast
Protective immunity induced by Bacillus anthracis toxin-deficient strains.
@en
prefLabel
Protective immunity induced by Bacillus anthracis toxin-deficient strains.
@ast
Protective immunity induced by Bacillus anthracis toxin-deficient strains.
@en
P2093
P2860
P1476
Protective immunity induced by Bacillus anthracis toxin-deficient strains
@en
P2093
P2860
P304
P407
P577
1995-04-01T00:00:00Z